Full Text View
Tabular View
No Study Results Posted
Related Studies
Irbesartan Versus Amlodipine: The OBI Study
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Aristotle University Of Thessaloniki.
Recruitment status was  Not yet recruiting
Study NCT00987662   Information provided by Aristotle University Of Thessaloniki

First Received on September 30, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
Hypertension
More general conditions related to this trial
Body Weight
Cardiovascular Diseases
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Irbesartan
Amlodipine
Additional drug interventions recognized in this trial
Hydrochlorothiazide
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Diuretics
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Chloride Symporter Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Aristotle University Of Thessaloniki


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services